"Nitroarginine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
| Descriptor ID |
D019335
|
| MeSH Number(s) |
D12.125.068.050.587 D12.125.095.104.587
|
| Concept/Terms |
Nitroarginine- Nitroarginine
- NOARG
- omega-Nitroarginine
- omega Nitroarginine
- NO2Arg
- NG-Nitro-L-Arginine
- NG Nitro L Arginine
- N(omega)-Nitroarginine
- NG-Nitroarginine
- NG Nitroarginine
- N(G)-Nitroarginine
- N omega-Nitro-L-Arginine
- N omega Nitro L Arginine
- omega-Nitro-L-Arginine, N
|
Below are MeSH descriptors whose meaning is more general than "Nitroarginine".
Below are MeSH descriptors whose meaning is more specific than "Nitroarginine".
This graph shows the total number of publications written about "Nitroarginine" by people in this website by year, and whether "Nitroarginine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitroarginine" by people in Profiles.
-
Long-term depression in the superior cervical ganglion of the rat. Brain Res. 2008 Oct 09; 1234:25-31.
-
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2628-33.
-
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation. 2002 Jun 11; 105(23):2785-90.
-
Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO. Am J Physiol Heart Circ Physiol. 2001 Dec; 281(6):H2270-81.
-
Divergent effects of NO synthase inhibition on systemic and myocardial O2 delivery and consumption during dobutamine infusion in sheep. Pflugers Arch. 2002 Feb; 443(4):601-8.
-
Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin. Zhongguo Yao Li Xue Bao. 1999 Apr; 20(4):333-7.
-
Nitric oxide is required for the maintenance but not initiation of ganglionic long-term potentiation. Neuroscience. 1999; 94(3):897-902.
-
Increased aortic blood pressure contributes to potentiated dobutamine inotropic responses after systemic NO synthase inhibition in sheep. Cardiovasc Res. 1998 Nov; 40(2):282-9.
-
Inward rectifier potassium channels in the rat middle cerebral artery. Am J Physiol. 1998 02; 274(2):R541-7.
-
Nitric oxide mediates long-term potentiation in rat superior cervical ganglion. Brain Res. 1997 Apr 11; 753(2):315-7.